Naldecon-CX Trademark Details

Naldecon-Cx was registered on Tuesday, April 1, 1980 and is currently owned by Bristol-Myers Squibb Company under the registration number 1132065 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, March 11, 2016, according to the United State Patent & Trademark Office
Word Mark Naldecon-Cx
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company

Previous Owners

Bristol-Myers Company of New York, NY

View all trademarks for Bristol-Myers Company
Other Trademarks for Bristol-Myers Company
Serial Number 73204682
Registration Number 1132065
Status Date Friday, March 11, 2016
Filing Date Friday, March 11, 2016
Registration Date Tuesday, April 1, 1980

Correspondent

NADINE P. FLYNN, ESQ.
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVE.
NEW YORK NY 10154

Case File Statements

Goods & Services Nasal Decongestant
Pseudo Mark Cx

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, March 11, 2016
First Use Anywhere Wednesday, December 13, 1978
First Use In Commerce Wednesday, December 13, 1978
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.